Protocol Ledger

NCT06075745 · Phase II · RECRUITING

Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

Interventional Phase II clinical trial protocol NCT06075745 sponsored by National Institute of Allergy and Infectious Diseases (NIAID) in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-03-05 Enrollment: 416 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06075745
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)416 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06075745
Protocol FieldVerified Registry Value
NCT IdentifierNCT06075745
Consolidated Lead SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment416 participants (ESTIMATED)
Registered Start Date2024-03-05
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI